Retina news: What's hot (and not)

Video
Conference|SECO

Mohammad Rafieetary, OD, FAAO, offers a sneak peek at the latest (and fake!) news in retina.

During SECO 2022, Mohammad Rafieetary, OD, FAAO, consultative optometric physician at the Charles Retina Institute in Germantown, Tennessee, offers Optometry Times®' Alex Delaney-Gesing a sneak peek at the latest news in retina— including for diabetic retinopathy and age-related macular degeneration (AMD) —as well as common "fake news" circualting in medicine as a whole.

See more conference coverage

Recent Videos
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
EnVision Summit Cochair Cecelia Koetting, OD, FAAO, Dipl ABO, says that attendees should get ready for more discussion-based panels at this year's conference.
Bonnie An Henderson in an interview for the EnVision Summit
EnVision Summit cofounder and program chair Dr Bonnie Henderson chats about collaborative eye care
Bonnie An Henderson in an interview for the EnVision Summit
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Related Content
patient with diabetes undergoes retinal exam following implantation of axitinib intravitreal implant as part of HELIOS trial - Image credit: Adobe Stock / ©Peakstock

HELIOS trial: Promising 1-Year results of phase I study for treating NPDR

Lynda Charters
January 27th 2025
Article
Optometry Times You and Eye

You and Eye: What optometrists need to know about low vision

Miriam Korik, OD;Emily Kaiser Maharjan, Assistant Managing Editor
March 13th 2024
Podcast
Physician consoling older patient Image credit: AdobeStock/LIGHTFIELDSTUIDOS

US FDA grants Fast Track designation for NPI-001 tablets for treatment of retinitis pigmentosa

Jordana Joy, Associate Editor
January 22nd 2025
Article
Advances in treatment for geographic atrophy

Advances in treatment for geographic atrophy

David S. Boyer, MD;Tina Mac Donald, OD, CDCES, FAAO;Leo P. Semes, OD, FAAO
October 11th 2023
Podcast
Ocugen announces 2-year safety and efficacy update for Phase 1_2 OCU400 for the treatment of RP - Image credit: Adobe Stock / ©Flashizzle_peopleimages.com

Ocugen announces 2-year safety and efficacy update for Phase 1/2 OCU400 for the treatment of RP

Sydney M Crago, Editor, Modern Retina
January 20th 2025
Article
Samsara Vision publishes positive imtermediate-term visual and safety outcomes of SING IMT - Image credit: Adobe Stock / ©Photocreo Bednarek

Positive intermediate-term visual and safety outcomes of SING IMT 6 months post-surgery announced by Samsara Vision

Martin David Harp, Associate Editor, Ophthalmology Times
January 20th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.